SAKAR Share Price Performance
₹336.95
32.25 (10.58%)
Price ₹336.95
Share Price₹336.95
SAKAR Community Narratives
There are no narratives available yet.
Recent SAKAR News & Updates
No updates
Sakar Healthcare Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 9.09
- Gross Margin
- 52.87%
- Net Profit Margin
- 10.45%
- Debt/Equity Ratio
- 30.3%
Sakar Healthcare Limited Competitors
About SAKAR
- Founded
- 2004
- Employees
- 325
- CEO
- WebsiteView website
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Indian Market Performance
- 7 Days: -1.1%
- 3 Months: 5.6%
- 1 Year: -4.1%
- Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.7%, driven by a loss of 1.3% in the Communication Services sector. As for last year, the market is also down 4.7%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading